These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7436099)

  • 21. Attempts at immunizing cattle against anaplasmosis using a killed vaccine.
    McHardy N; Simpson RM
    Trop Anim Health Prod; 1973 Aug; 5(3):166-73. PubMed ID: 4802404
    [No Abstract]   [Full Text] [Related]  

  • 22. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
    Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplasma marginale infections in American bison: experimental infection and serologic study.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1985 Feb; 46(2):438-41. PubMed ID: 3994109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-yield preparation of purified Anaplasma marginale from infected bovine red blood cells.
    McCorkle-Shirley S; Hart LT; Larson AD; Todd WJ; Myhand JD
    Am J Vet Res; 1985 Aug; 46(8):1745-7. PubMed ID: 3898932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of vaccine-induced immunity to anaplasmosis without induction of persistent postvaccinal complement-fixing and agglutinating antibodies in yearling steers.
    Corrier DE; Johnson JS; Wagner GG
    Am J Vet Res; 1985 Mar; 46(3):583-6. PubMed ID: 3994127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frozen Anaplasma centrale vaccine against anaplasmosis in cattle.
    Pipano E; Krigel Y; Frank M; Markovics A; Mayer E
    Br Vet J; 1986; 142(6):553-6. PubMed ID: 3594187
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunization against anaplasmosis and babesiosis. Part II. Evaluation of cryo-preserved vaccines using different doses and routes of inoculation.
    Todorovic R; Gonzalez E; Lopez G
    Tropenmed Parasitol; 1978 Jun; 29(2):210-4. PubMed ID: 675843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen beads: a novel approach for the delivery of a soluble Anaplasma immunogen.
    James MA; Coronado A; Melendez RD; Ristic M
    Am J Vet Res; 1984 Oct; 45(10):2123-5. PubMed ID: 6388435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous hypersensitivity and isoantibody production in cattle injected with live or inactivated Anaplasma marginale in bovine and ovine erythrocytes.
    Carson CA; Sells DM; Ristic M
    Am J Vet Res; 1976 Sep; 37(9):1059-63. PubMed ID: 962206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaplasma marginale field challenge: protection by an inactivated immunogen that shares partial sequence of msp1alpha variable region with the challenge strain.
    Vega LE; Rodríguez SD; Alarcón GJ; Flores RL; Ocampo RJ; Ortiz MA; de la Torre JF; Ramírez EE
    Vaccine; 2007 Jan; 25(3):519-25. PubMed ID: 17049686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis.
    Montenegro-James S; James MA; Benitez MT; Leon E; Baek BK; Guillen AT
    Parasitol Res; 1991; 77(2):93-101. PubMed ID: 2027888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premunization with an attenuated Anaplasma marginale.
    Kuttler KL; Zaraza H
    Proc Annu Meet U S Anim Health Assoc; 1969; 73():104-12. PubMed ID: 5278167
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of an attenuated Anaplasma marginale of deer origin as an anaplasmosis vaccine.
    Kuttler KL; Zaugg JL
    Trop Anim Health Prod; 1988 May; 20(2):85-91. PubMed ID: 3400115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant infection of cattle with the vaccine strain Anaplasma marginale ss centrale and field strains of A. marginale.
    Shkap V; Leibovitz B; Krigel Y; Molad T; Fish L; Mazuz M; Fleiderovitz L; Savitsky I
    Vet Microbiol; 2008 Aug; 130(3-4):277-84. PubMed ID: 18387757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative titration of Anaplasma marginale antibodies by card agglutination and complement-fixation tests.
    Amerault TE; Rose JE; Kuttler KL
    Am J Vet Res; 1981 Jun; 42(6):1055-6. PubMed ID: 7283236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infectivity virulence and immunogenicity of Anaplasma centrale live blood vaccine.
    Potgieter FT; Van Rensburg L
    Onderstepoort J Vet Res; 1983 Mar; 50(1):29-31. PubMed ID: 6348636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaplasma marginale: lack of cross-protection between strains that share MSP1a variable region and MSP4.
    Ocampo Espinoza V; Vázquez JE; Aguilar MD; Ortiz MA; Alarcón GJ; Rodríguez SD
    Vet Microbiol; 2006 Apr; 114(1-2):34-40. PubMed ID: 16386388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with an isolate-common surface protein protects cattle against anaplasmosis.
    Palmer GH; Barbet AF; Davis WC; McGuire TC
    Science; 1986 Mar; 231(4743):1299-302. PubMed ID: 3945825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of protective immunity in bovine anaplasmosis.
    Carson CA; Ristic M
    Proc Annu Meet U S Anim Health Assoc; 1977; (81):69-71. PubMed ID: 286365
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of IgG2-specific antigens in Mexican Anaplasma marginale strains.
    Barigye R; García-Ortiz MA; Rojas Ramírez EE; Rodríguez SD
    Ann N Y Acad Sci; 2004 Oct; 1026():84-94. PubMed ID: 15604474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.